We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
138 hedge funds and large institutions have $412M invested in Amphastar Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
48.56% more ownership
Funds ownership: 0% → 48.56% (+49%)
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
3% more funds holding
Funds holding: 134 → 138 (+4)
2% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 48
1% less capital invested
Capital invested by funds: $418M → $412M (-$6.27M)
Holders
138
Holders Change
+4
Holders Change %
+2.99%
% of All Funds
3.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
49
Reduced
48
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$15.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.63M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.3M |
| 4 |
Goldman Sachs
New York
|
+$2.4M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.93M |
